Primary biliary cholangitis (PBC) is a chronic liver disease characterized by the progressive destruction of the bile ducts in the liver, leading to cholestasis and potential liver failure. Since the groundbreaking approval of ursodeoxycholic acid (UDCA) in 1997, treatments have evolved significantly, offering hope to many patients. However, the complexities of PBC necessitate a deeper
Health
Crohn’s disease, a chronic inflammatory bowel disorder, can present a significant therapeutic challenge, particularly for patients who have not responded to standard biological therapies. The recent results of a pivotal phase III trial examining mirikizumab, a humanized monoclonal antibody targeting interleukin-23 (IL-23), offer new hope for these patients. This article delves into the findings, methodologies,
Recent research from France has drawn attention to the link between the consumption of ultraprocessed foods and the severity of psoriasis, a chronic inflammatory skin condition. Conducted within the expansive NutriNet-Santé cohort, this study reveals compelling associations that underscore the importance of diet in managing psoriasis symptoms. The research indicates that individuals with active psoriasis
In a significant move aimed at improving patient access to care, the Biden-Harris administration has introduced a proposed rule that promises to make prior authorization protocols and coverage criteria for Medicare Advantage plans more transparent and accessible. The Centers for Medicare & Medicaid Services (CMS) has actively worked over the last three years to tackle
The landscape of neurosurgery has seen significant advancements over the years, particularly in how preoperative interventions can influence surgical outcomes. A recent study presented at the Society for NeuroOncology meeting explores the effects of preoperative embolization on meningiomas—a type of brain tumor—and presents important implications for clinical practice. By analyzing data from a cohort of
The medical field often grapples with complex issues, ranging from drug approvals to the integration of new research findings into healthcare practices. Recent discussions among prominent healthcare professionals showcase various challenges, insights, and the evolving landscape of medicine, particularly in how regulations impact both patient care and the healthcare workforce. One of the most pressing
The recent appointments made by President-elect Donald Trump signal an unmistakable shift in the leadership of U.S. health agencies. By nominating former Republican Congressman Dave Weldon, MD, to head the Centers for Disease Control and Prevention (CDC) and Janette Nesheiwat, MD, as the next Surgeon General, Trump aims to restore confidence among specific sectors of
The recent selection of Dr. Marty Makary as the prospective head of the U.S. Food and Drug Administration (FDA) marks a pivotal moment in the trajectory of how healthcare and regulatory oversight might be approached in the Trump administration. As the nation grapples with trust issues related to regulatory bodies, trust-building, innovative reform, and a
Chronic pain is a significant health challenge in the United States, impacting millions of individuals and influencing how they navigate daily life. A recent survey from the Centers for Disease Control and Prevention (CDC) reveals worrying statistics that suggest nearly one in four adults in the U.S. suffers from chronic pain. This article seeks to
In a landmark move, a joint advisory committee convened by the Food and Drug Administration (FDA) has voted overwhelmingly in favor of eliminating the Risk Evaluation and Mitigation Strategy (REMS) pertaining to clozapine, a critical medication used in the treatment of schizophrenia and schizoaffective disorder. This decision, which saw 14 out of 15 panelists expressing